Performance of point-of-care HbA 1c test devices: implications for use in clinical practice – a systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Background: Point-of-care (POC) devices could be used to measure hemoglobin A 1c (HbA 1c ) in the doctors’ office, allowing immediate feedback of results to patients. Reports have raised concerns about the analytical performance of some of these devices. We carried out a systematic review and meta-analysis using a novel approach to compare the accuracy and precision of POC HbA 1c devices. Methods: Medline, Embase and Web of Science databases were searched in June 2015 for published reports comparing POC HbA 1c devices with laboratory methods. Two reviewers screened articles and extracted data on bias, precision and diagnostic accuracy. Mean bias and variability between the POC and laboratory test were combined in a meta-analysis. Study quality was assessed using the QUADAS2 tool. Results: Two researchers independently reviewed 1739 records for eligibility. Sixty-one studies were included in the meta-analysis of mean bias. Devices evaluated were A1cgear, A1cNow, Afinion, B-analyst, Clover, Cobas b101, DCA 2000/Vantage, HemoCue, Innovastar, Nycocard, Quo-Lab, Quo-Test and SDA1cCare. Nine devices had a negative mean bias which was significant for three devices. There was substantial variability in bias within devices. There was no difference in bias between clinical or laboratory operators in two devices. Conclusions: This is the first meta-analysis to directly compare performance of POC HbA 1c devices. Use of a device with a mean negative bias compared to a laboratory method may lead to higher levels of glycemia and a lower risk of hypoglycaemia. The implications of this on clinical decision-making and patient outcomes now need to be tested in a randomized trial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, deviations near key clinical thresholds, such as 6.5% for diagnosis or 7.0-8.0% for treatment decisions, may result in misclassification and inappropriate therapeutic interventions (9,10).”
From Comparison of point‑of‑care HbA1c devices with laboratory HPLC methods: A systematic review and meta‑analysis (2026) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous reviews have emphasized that such variability remains a persistent challenge in standardizing HbA1c measurement across platforms and settings (10,35).”
From Comparison of point‑of‑care HbA1c devices with laboratory HPLC methods: A systematic review and meta‑analysis (2026) · cites this paper as [10]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A meta-analysis published in 2017 revealed continuing problems with the accuracy of POCT devices (324).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [324]
The cited source says what the claim attributes to it.
In the citing paper
“Analysis of 60 studies with 13 devices showed that most devices had negative bias (all the others had positive bias) and large standard deviations.”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [324]
The cited source says what the claim attributes to it.
In the citing paper
“For example, a prior meta-analysis reported substantial variability in bias across different POC platforms, with some devices showing deviations beyond clinically acceptable limits (10).”
From Comparison of point‑of‑care HbA1c devices with laboratory HPLC methods: A systematic review and meta‑analysis (2026) · cites this paper as [10]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“Data on mean bias between POC and laboratory HbA1c and SD mean bias were combined using random effects DerSimonian and Laird meta-analysis [15] as recommended for meta-analyses of method comparison studies with considerable heterogeneity [16].”
Method(1965) · The Lancet · doi:10.1016/s0140-6736(65)91037-8 · Cited by 16,856
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059 · cited 2×
“The long-term effects of this are not known, but studies have shown that even small increases in HbA1c increase the risk of micro- and macrovascular complications [1].”
BackgroundInterpretation of random effects meta-analyses
Riley, R. D., Higgins, J. P. T., & Deeks, J. J. (2011) · BMJ · doi:10.1136/bmj.d549 · Cited by 2,884
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
metandi: Meta-analysis of diagnostic accuracy using hierarchical logistic regression
Harbord, R. M., & Whiting, P. (2009) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0900900203 · Cited by 453 · cited 3×
“All analyses were carried out using Stata 12.0SE (StataCorp, College Station, TX, USA).”
MethodInfluentialCagliero, E., Levina, E. V., & Nathan, D. M. (1999) · Diabetes Care · doi:10.2337/diacare.22.11.1785 · Cited by 246 · cited 2×
“Sixteen studies reported receiving funding from the POC device manufacturers [7, 9, 27, 30, 35, 36, 39, 41, 47, 50, 51, 56, 58, 59, 65, 70].”
BackgroundMethodLenters-Westra, E., & Slingerland, R. J. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.130641 · Cited by 228 · cited 3×
“The suitability of many of these devices for the accurate measurement of HbA1c has been questioned, with some POC HbA1c test devices reported not to meet accepted accuracy and precision criteria [3].”
BackgroundMethod
Research works printed but not linked: 10
- 10. Wood JA, Kaminski BM, Kollman C, Diabetes P. The accuracy and precision of the axis-shield afinion HbA1c measure ment device. Diabetes 2011; Conference: 71st Scientific Sessions of the American Diabetes Association San Diego, CA United States. Conference Start: 20110624 Conference End: 20110628. Confer- ence Publication: (var.pagings). 60:A237.
- 11. Health Quality Ontario. Point-of-care hemoglobin A1c testing: an evidence-based analysis. Ont Health Technol Assess Ser 2014;14:1-30.
- 36. Clark AL, Irvin BR, Isbell AW, Ammirati EA. Multi-site correlation of A1cNow %A1C assay to a standardized laboratory. Clin Chem 2005;51:A259-A.
- 40. Estevez Fidalgo P, Pineiro Caamano A, Otero Santiago M, Garcia Aschauer JM, Lorenzo Freire MT, Espana Barrada R, et al. Valida- tion of HbA1c results obtained with a point of care instrument. Clin Chem Lab Med 2014;52:S1523.
- 43. Harris S, Tokmakejian S, Edmonds M, Webster-Bogaert S, Mahon J, Porter S, et al. Validation of the bayer DCA2000 (TM) as a point-of-care measure of glycosylated haemoglobin. Diabetes 2000;49:A110-A.
- 45. Heng PY, Fun S, Chui KL, Taufik MA, Lew MY, Wong MS. An evalu- ation of the performance of Roche Cobas b101 point-of-care system in the measurement of haemoglobin A1C. Clin Chem Lab Med 2015;53:S623.
- 48. Jou JM, Bedini JL, Seuma J, Luna N, Kinder M. Evaluati on of the point of care a1cnow+ analy zer for HBA1C. International Journal of Laboratory Hematology 2013; Conference: 26th Interna- tional Symposium on Technological Innovations in Laboratory Hematology, ISLH 2013 Toronto, ON Canada. Conference Start: 20130510 Conference End: 20130512. Conference Publication: (var.pagings). 35:50.
- 63. Rossi L, Della Bartola L, Giampietro O, Consani C, Pellegrini G, Matteucci E. Point-of-care hbA1c testing in a clinical setting: performance analysis. Clin Chem Lab Med 2015;53:S543.
- 71. Thueringer JT, Ishani A, Rector T, Greer N, Ercan-Fang N. Compar- ison of a1c measurements from a home test device to a hospital laboratory. Diabetes 2012; Conference: 72nd Scientific Sessions of the American Diabetes Association Philadelphia, PA, United States. Conference Start: 20120608 Conference End: 20120612. Conference Publication: (var.pagings). 61:A218.
- 75. Williams PF, Tan K, Sherfan J, Woolnough C, Lin E, Brown M, et al. Comparison of three point of care (POC) HbA1c devices with cation exchange and capillary electrophoresis. Diabetes 2014;63:A220.
Cited by
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Early Outcomes From the English National Health Service Diabetes Prevention Programme
Valabhji, J., Barron, E., Bradley, D., Bakhai, C., Fagg, J., O’Neill, S., Young, B., Wareham, N., Khunti, K., Jebb, S., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1425 · Cited by 211
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 206
HbA1c: a review of non-glycaemic variables
Campbell, L., Pepper, T., & Shipman, K. E. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2017-204755 · Cited by 105
“Systematic review of POCT against laboratory methods suggests unacceptable imprecision with an overall negative bias in some POCT devices limiting their use in both diagnosis and management.(31) However, precision varies depending on platform with potentially some analysers performing adequately though the American Di…”
Berard, L. D., Siemens, R., & Woo, V. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.007 · Cited by 69
Patel, M. R., Zhang, G., Heisler, M., Song, P. X. ‐., Piette, J. D., Shi, X., Choe, H. M., Smith, A. L., & Resnicow, K. (2022) · Diabetes Care · doi:10.2337/dc22-0494 · Cited by 68
HbA1c method performance: The great success story of global standardization
English, E., & Lenters‐Westra, E. (2018) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2018.1480591 · Cited by 82
“Another mechanism is through performance in EQA programmes, however many POC devices are not entered into such programmes due to a lack of regulation or waiving of regulations and therefore there is limited data around the true performance of these instruments (20, 23, 24, 42-46).”
BackgroundSelf-citationAACC guidance document on management of point-of-care testing
Nichols, J. H., Alter, D., Chen, Y., Isbell, T. S., Jacobs, E., Moore, N., & Shajani-Yi, Z. (2020) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaa059 · Cited by 63
Current Status of HbA1c Biosensors
Lin, H., & Yi, J. (2017) · Sensors · doi:10.3390/s17081798 · Cited by 65
“In a very recent review, Hirst and coworker independently reviewed 1739 records published before June 2015 in several databases (Medline, Embase and Web of Science) and carried out a meta-analysis on sixty-one studies to compare the accuracy and precision of eleven HbA1c POC devices [75].”
BackgroundGlycated Hemoglobin and Methods for Its Point of Care Testing
Pohanka, M. (2021) · Biosensors · doi:10.3390/bios11030070 · Cited by 56
Epstein, L. H., Paluch, R. A., Biondolillo, M. J., Stein, J. S., Quattrin, T., Mastrandrea, L. D., Gatchalian, K. M., Greenawald, M. H., & Bickel, W. K. (2022) · Journal of Behavioral Medicine · doi:10.1007/s10865-021-00278-y · Cited by 50
Lin, C.-S., Lee, Y.-T., Fang, W.-H., Lou, Y.-S., Kuo, F.-C., Lee, C.-C., & Lin, C. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080725 · Cited by 39
Hatada, M., Tran, T., Tsugawa, W., Sode, K., & Mulchandani, A. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.09.069 · Cited by 42
Point-of-care HbA1c in clinical practice: caveats and considerations for optimal use
Sacks, D. B., Kirkman, M. S., & Little, R. R. (2024) · Diabetes Care · doi:10.2337/dci23-0040 · Cited by 29
Diabetic foot ulcers: treatment overview and cost considerations
Moore, Z. E. H., Avşar, P., Wilson, P., Mairghani, M., O’Connor, T., Nugent, L., & Patton, D. (2021) · Journal of Wound Care · doi:10.12968/jowc.2021.30.10.786 · Cited by 43
Patel, M. R., Zhang, G., Leung, C. W., Song, P. X. ‐., Heisler, M., Choe, H. M., Mehdipanah, R., Shi, X., Resnicow, K., Rajaee, G., et al. (2021) · Primary care diabetes · doi:10.1016/j.pcd.2021.10.004 · Cited by 28
Patel, M. R., Tolentino, D. A., Smith, A. L., & Heisler, M. (2023) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2023.102246 · Cited by 31
Accuracy and Precision of a Point-of-Care HbA1c Test
Arnold, W. D., Kupfer, K., Little, R. R., Amar, M., Horowitz, B., Godbole, N., Swensen, M. H., Li, Y., & George, R. C. S. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819831292 · Cited by 35
Barron, E., Misra, S., English, E., John, W. G., Sampson, M., Bachmann, M. O., Barth, J. H., Oliver, N. S., Alberti, K. G. M. M., Bakhai, C., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001703 · Cited by 26
Self-citationOrtiz‐Martínez, M., Flores-DelaToba, R., González‐González, M., & Rito‐Palomares, M. (2021) · Biosensors · doi:10.3390/bios11120482 · Cited by 27
Chivese, T., Hirst, J. A., Matizanadzo, J. T., Custodio, M., Farmer, A. A., Norris, S. A., & Levitt, N. S. (2021) · Diabetic Medicine · doi:10.1111/dme.14754 · Cited by 27
Self-citationHeinemann, L., Kaiser, P., Freckmann, G., Grote-Koska, D., Kerner, W., Landgraf, R., Merker, L., Müller, U. A., Müller‐Wieland, D., Roth, J., et al. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0721-2273 · Cited by 25
“There are significant differences in particular between the POCT systems themselves which appear to fulfill the tighter quality requirements to varying degrees [30, 31].”
BackgroundBuilding Toward a Population-Based Approach to Diabetes Screening and Prevention for US Adults
Bowen, M. E., Schmittdiel, J. A., Kullgren, J. T., Ackermann, R. T., & O’Brien, M. J. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1090-5 · Cited by 23
Reconfigurable multiplexed point of Care System for monitoring type 1 diabetes patients
Márquez, A., Aymerich, J., Dei, M., Rodríguez‐Rodríguez, R., Vázquez‐Carrera, M., Pizarro‐Delgado, J., Giménez-Gómez, P., Merlos, Á., Terés, L., Serra-Graells, F., et al. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.04.015 · Cited by 23
Yauch, L. M., Velazquez, E. P., Piloya, T., Mungai, L., Omar, A. A., & Moran, A. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.135 · Cited by 28
Gourlay, A., Sutherland, C. D., & Radley, A. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2023.10.011 · Cited by 27
Hirst, J. A., Stevens, R., Smith, I., James, T., Gudgin, B., & Farmer, A. A. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.05.014 · Cited by 25
“[20] Hirst JA, McLellan JH, Price CP, English E, Feakins BG, Stevens RJ, et al.”
BackgroundMethodSelf-citationCost-Effectiveness of Point-of-Care A1C Tests in a Primary Care Setting
Rosa, L. D. S., Mistro, S., Oliveira, M. G., Kochergin, C. N., Cortes, M. L., de Medeiros, D. S., Soares, D. A., Louzado, J. A., Silva, K. O., Bezerra, V. M., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.588309 · Cited by 29
Blum, J. A., Chaney, M., Mudji, J., Mfungwa, J.-A. K., Rice, T. D., & Labhardt, N. D. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.08.002 · Cited by 20
Hayek, A. A., Alsaeed, A. H., Alzahrani, W. M., & Dawish, M. A. A. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01126-7 · Cited by 24
Gillery, P. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-0894 · Cited by 30
“A meta-analysis published in 2017 evidenced a substantial variability in bias within devices, emphasizing that devices with a significant bias compared to laboratory methods could influence decision-making [49].”
BackgroundHbA1c-Messung in Deutschland: Ist die Qualität ausreichend für Verlaufskontrolle und Diagnose?
Heinemann, L., Kaiser, P., Freckmann, G., Grote-Koska, D., Kerner, W., Landgraf, R., Merker, L., Müller, U. A., Müller‐Wieland, D., Roth, J., et al. (2018) · Diabetologie und Stoffwechsel · doi:10.1055/s-0043-125187 · Cited by 20
“Es gibt dabei deutliche Unterschiede insbesondere zwischen den POCT-Systemen selbst, die höhere Qualitätsanforderungen anscheinend unterschiedlich gut erfüllen [27, 28].”
BackgroundStranieri, A., Venkatraman, S., Minicz, J., Zarnegar, A., Firmin, S., Balasubramanian, V., & Jelinek, H. F. (2022) · Smart Health · doi:10.1016/j.smhl.2022.100279 · Cited by 20
Steinbrook, E., Flood, D., Barnoya, J., Montano, C. M., Miller, A. C., & Rohloff, P. J. (2022) · Global Heart · doi:10.5334/gh.1171 · Cited by 17
Grant, D. M., Tomlinson, D. J., Tsintzas, K., Kolić, P. V., & Onambélé-Pearson, G. L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.574595 · Cited by 22
“Accordingly, both Accutrend and Hemocue have shown good reliability (Luley et al., 2000; Newman and Turner, 2005; Phillips et al., 2014) and validity (Luley et al., 2000; Coqueiro et al., 2014; Hirst et al., 2017), when compared to laboratory testing.”
BackgroundTollånes, M. C., Jenum, A. K., Berg, T. J., Løvaas, K. F., Cooper, J. G., & Sandberg, S. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0026 · Cited by 20
“This is supported by a 2017 meta-analysis, which did not find overall systematic differences between the two most commonly used HbA1c POC instruments in Norway and various hospital comparator methods [20].”
MethodCamargo, M. S., Passos, L. C. S., Mistro, S., Soares, D. A., Kochergin, C. N., de Carvalho, V. C. H. D. S., Macedo, J. C. L., Cortes, T. B. A., de Souza, A. A., Rumel, D., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.734306 · Cited by 15
Njoroge, A., Augusto, O. J., Page, S. T., Kigondu, C., Oluka, M. N., Puttkammer, N. H., & Farquhar, C. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.292 · Cited by 13
Commentary: Diagnostic Validity and Clinical Utility of HbA1c Tests for Type 2 Diabetes Mellitus
Owora, A. H. (2016) · Current Diabetes Reviews · doi:10.2174/1573399812666161129154559 · Cited by 15
Woo, J., Whyne, E. Z., Wright, J. I., Lehrer, H. M., Alhalimi, T., Wang, T., Saba, V. C., Dubois, S. K., Tanaka, H., Brown, S. A., et al. (2022) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106221100536 · Cited by 14
Yonel, Z., Kuningas, K., Sharma, P., Dutton, M., Jalal, Z., Cockwell, P., Webber, J., Narendran, P., Dietrich, T., & Chapple, I. (2022) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-022-01999-z · Cited by 14
“The DCA vantage was one of two devices to show no difference in bias between clinical or laboratory operators, thus suggesting reduced technique sensitivity and ease of use in the clinical setting [38].”
BackgroundResultInfluentialPatel, M. R., Zhang, G., Heisler, M., Piette, J. D., Resnicow, K., Choe, H. M., Shi, X., & Song, P. X. ‐. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-024-08708-8 · Cited by 13
Exploring Saliva as a Sample for Non-Invasive Glycemic Monitoring in Diabetes: A Scoping Review
Calixto, P. S., Ferraz, F. C., Dutra, G. C., Pelozzo, M. J. B., Trovão, M. E., Rego, F. G. D. M., Picheth, G., Campelo, P. M. S., & Sari, M. H. M. (2025) · Biomedicines · doi:10.3390/biomedicines13030713 · Cited by 14
The Relationship between Macronutrient Distribution and Type 2 Diabetes in Asian Indians
Pandya, A., Mehta, M., & Sankavaram, K. (2021) · Nutrients · doi:10.3390/nu13124406 · Cited by 12
Advances in Nanomaterial-based Biosensors for Determination of Glycated Hemoglobin
Noviana, E., Siswanto, S., & Hastuti, A. A. M. B. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666220915114646 · Cited by 11
Analysis: Investigating the quality of POCT devices for HbA1c, what are our next steps?
Lenters‐Westra, E., & English, E. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819850838 · Cited by 12
Self-citationMillán-Ferro, A., Garcia-Dolagaray, G., Gautam, S., Caballero, A. E., & Mitri, J. (2020) · Clinical Diabetes · doi:10.2337/cd19-0086 · Cited by 11
“Wide variability has been described in this and similar devices (18).”
BackgroundAre hemoglobin A1c point-of-care analyzers fit for purpose? The story continues
Lenters‐Westra, E., & English, E. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-1308 · Cited by 15
Self-citationHbA1c-testing: Evaluation of two point-of-care analysers
Dubach, I. L., Christ, E. R., & Diem, P. (2019) · Primary Care Diabetes · doi:10.1016/j.pcd.2019.05.007 · Cited by 9
Gurney, S. C., Christison, K. S., Williamson-Reisdorph, C. M., Sol, J. A., Quindry, T. S., Quindry, J. C., & Dumke, C. L. (2021) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000002191 · Cited by 9
How can point-of-care technologies support in-hospital diabetes care?
Misra, S., Avari, P., Lumb, A., Flanagan, D., Choudhary, P., Rayman, G., & Dhatariya, K. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221137360 · Cited by 9
O’Brien, M. J., & Sacks, D. B. (2019) · JAMA · doi:10.1001/jama.2019.14063 · Cited by 8
Kubiak, R. W., Kratz, M., Motala, A. A., Galagan, S. R., Govere, S., Brown, E. R., Moosa, M. S., & Drain, P. K. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06473-1 · Cited by 10
“9%) were reasonable for a pointof-care test, although not below the recommended level of < 2% [47].”
BackgroundSmits, M., Hopstaken, R., Terhaag, L., de Kort, G., & Giesen, P. H. J. (2022) · BMC Nursing · doi:10.1186/s12912-022-00969-0 · Cited by 11
“Reliable and user-friendly HbA1c POCT can be done with a few different POCT devices [13, 14].”
MethodAbildgaard, A. M., Knudsen, C. S., Bjerg, L. N., Lund, S. A., & Støy, J. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0720 · Cited by 10
Shakya, P., Shrestha, A., Karmacharya, B. M., Shrestha, A., Kulseng, B. E., Skovlund, E., & Sen, A. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-064516 · Cited by 8
Which Point-of-Care Tests Would Be Most Beneficial to Add to Clinical Practice?
Hardy, V., Alto, W. A., Keppel, G. A., Baldwin, L., & Thompson, M. J. (2017) · Point of Care The Journal of Near-Patient Testing & Technology · doi:10.1097/poc.0000000000000151 · Cited by 6
“Indeed, concerns about the variability of POCT hemoglobin A1c results compared with laboratory measurements have been reported in both qualitative(11) and diagnostic accuracy studies.(13) Clinicians identified RTIs as a condition for which POCTs would be useful, but did not report as beneficial the existing POCTs for…”
ResultAnderson, P., Grills, N., Singh, R. P., Singh, R., Evans, R. G., Sengupta, P., & Thrift, A. G. (2019) · BMC Public Health · doi:10.1186/s12889-019-7184-4 · Cited by 6
Reference ranges of glycated hemoglobin (HbA1c) in capillary blood in the Spanish population
Barroso, M., Baena-Díez, J. M., Muñoz‐Aguayo, D., Díaz, J. L., Schröder, H., & Grau, M. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.11.006 · Cited by 5
Point-of-Care Glycated Hemoglobin Testing to Diagnose Type 2 Diabetes
Foerster, V., & Severn, M. (2016) · Cited by 5
Recent advances in glycated hemoglobin test methods: From lab to point of care testing devices
Lakhera, P., Chaudhary, V. K., Kush, P., Kumar, P., Ughade, Y., Agrawal, L., Patel, G., & Deshmukh, K. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148742 · Cited by 6
Giachino, M., Vetter, B., Perone, S. A., Correia, J. C., Erkoşar, B., Heller, O., Khanal, V. K., Lab, B., Pataky, Z., Poudel, S., et al. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0003760 · Cited by 5
“This is critically important, considering variable field performance of point-of-care tests, [25–27] the lack of manufacturer-independent evaluations and the high number of on-market cardiometabolic POC devices [28].”
Wei, Y., Gu, M., Ren, Y., & Hu, Z. (2026) · Biomedical Reports · doi:10.3892/br.2026.2120 · Cited by 3
“Notably, deviations near key clinical thresholds, such as 6.5% for diagnosis or 7.0‑8.0% for treatment decisions, may result in misclassification and inappropriate therapeutic interventions (9,10).”
InfluentialShao, Q., Xie, X., Wang, L., Gao, L., Hu, Y., & Zhang, Y. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1438945 · Cited by 4
Accuracy of point‐of‐care HbA1c testing in pregnant women
Culliney, K. A., McCowan, L. M. E., Okesene-Gafa, K. A. M., Murphy, R., Rowan, J., Taylor, R. S., McKinlay, C. J. D., & the HUMBA Study Group (2018) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12786 · Cited by 6
Andersen, J. W., Dahl, M., Yderstræde, K. B., & Høgh, A. L. (2018) · Diabetic Medicine · doi:10.1111/dme.13759 · Cited by 3
Andrade, M. V., Noronha, K., Santos, A. S., Maia, J. X., Nogueira, L. T., Cimini, C. C. R., Furtado, M. E., Coelho, L., Marcolino, M. S., & Ribeiro, A. L. P. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2023.07.007 · Cited by 7
Recommendations for in-clinic PoCT for diabetes management in India
Saboo, B., SADIKOT, S. M., Kumar, K. M. P., Joshi, S., Aravind, S. R., Makkar, B. M., Chawla, R., Kesavadev, J., Chawla, M. S., KOVIL, R. R., et al. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.05.005 · Cited by 3
Freckmann, G. (2017) · Journal of Laboratory Medicine · doi:10.1515/labmed-2017-0089 · Cited by 3
Li, B., Kumar, A., Finlay, C., van Drimmelen, M., Barnes, E., Southby, S., & Florkowski, C. M. (2023) · Pathology · doi:10.1016/j.pathol.2023.07.004 · Cited by 3
Predictors of Interest in Offered Social Care Assistance Among People with Uncontrolled Diabetes
Patel, M. R., Smith, A. L., Torby, M., Isaacson, N. F., & Cohen, A. J. (2022) · Population Health Management · doi:10.1089/pop.2022.0186 · Cited by 2
Impact of sickle cell trait on glycated hemoglobin levels in Abidjan
Kouzahon, C. J. L., Chibrou, B. Y.-K. A., Louise, M., Christian, E., Benita, B.-N., Boni, G.-M. K., Youssouf, B. S. B., Jonas, V. B. F., Niamké, G., Konan, G. K., et al. (2025) · African Journal of Biochemistry Research · doi:10.5897/ajbr2024.1193 · Cited by 1
Zhang, H., Zhang, R., Jiao, D., Wang, B., Zhao, H., Fan, X., & Chang, H. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.114899 · Cited by 1
Breaking boundaries: A new era in glycemic assessment for type 2 diabetes patients
Das, S., Meher, D., & Patra, S. (2024) · National Journal of Pharmacology and Therapeutics · doi:10.4103/njpt.njpt_43_24 · Cited by 1
Inverse Association Between Betel Quid Use and Diabetes in Rural Bangladesh
Sznajder, K. K., Shenk, M. K., Pérez, L., Nh, A., Raqib, R., Kumar, A., Haque, F., Blumenfield, T., Cully, S. M., & Wander, K. (2026) · American Journal of Human Biology · doi:10.1002/ajhb.70203 · Cited by 1
Mayfield, J., & Samoszuk, M. K. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-0835 · Cited by 1
Abildgaard, A. M., Knudsen, C. S., Bjerg, L. N., Lund, S. A., & Støy, J. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-0915 · Cited by 1
Gourlay, A., Sutherland, C. D., & Radley, A. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4533581 · Cited by 1
Relationship Between HbA1c and Serum Magnesium Levels in Patients with Type 2 Diabetes Mellitus
Arslan, S., Erdoğdu, H. İ., & Atalay, E. (2021) · Kafkas Journal of Medical Sciences · doi:10.5505/kjms.2021.68878 · Cited by 1
Compliance of the POCT method with the fully automated method for HbA1c determination
Milinković, N., Matutinović, M. S., Dmitrašinović, G., & Ignjatović, S. (2022) · Arhiv za farmaciju · doi:10.5937/arhfarm72-35905
Füzéry, A. K., Kost, G. J., & Tran, N. K. (2022) · Wiley eBooks · doi:10.1002/9780470027318.a9797 · Cited by 1
Cook, S. G., Gin, L. M., Taylor, A. K., Markert, R. J., & Hughes, J. G. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2022.09.013
English, E. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch29 · Cited by 1
Self-citationPastakia, S. D., Schutz, H., Tiruneh, T., Vivero, A. G. D., & Dodds, L. (2025) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2025.e00450
Messung des HbA1c am Point-of-Care – klinische und praktische Aspekte
Schubert-Olesen, O., Niederau, C. M., Dänschel, I., Müller‐Wieland, D., & Wiesner, T. (2025) · Diabetologie und Stoffwechsel · doi:10.1055/a-2518-1369
“≥ 8%, 64mmol/mol) [22].”
Friedecky, B., & Kratochvíla, J. (2018) · Klinická biochemie a metabolismus · doi:10.61568/kbm.2018.024
POCT and diabetes - the need of complex and actual information
Friedecky, B., & Kratochvíla, J. (2017) · Klinická biochemie a metabolismus · doi:10.61568/kbm.2017.016
Vargas, E., Mark, J., Forlenza, G. P., & Triolo, T. M. (2025) · Diabetes Technology and Obesity Medicine · doi:10.1089/dtom.2025.0026
Khan, B. M., Currin, S., Mohamed, F., & Jacob, D. (2026) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2026.e00547
Smits, M., Hopstaken, R., Terhaag, L., de Kort, G., & Giesen, P. (2022) · Figshare · doi:10.6084/m9.figshare.20279447
Chhim, S., Ku, G., Kowal, P., Te, V., Sorithisey, M., Ngor, C., Walton, P., Maung, K. T., Ng, N., Naidoo, N., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-102715 · Cited by 4
“The explanatory variables included place of residence (urban or rural), sex (male or female), age (18–29, 30–39, 40–49, >50 years), level of education (none, primary, secondary, high school or higher) and wealth quin-tile, using principal component analysis (ranging from poorest to wealthiest).”
Daoutakou, M., & Kintzios, S. E. (2026) · Healthcare · doi:10.3390/healthcare14030309 · Cited by 1
Chhim, S., Kowal, P., Ng, N., Naidoo, N., Snodgrass, J. J., DeLouize, A. M., Ku, G. M., Sopheab, H., & Klipstein‐Grobusch, K. (2026) · Public Health · doi:10.1016/j.puhe.2026.106226 · Cited by 2
Genetically encoded FRET sensor for fructosyl valine detection in living cells
Soleja, N., Abid, M., & Mohsin, M. (2026) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2026.127887
Comparability of venous versus capillary hemoglobin A1c measurements
Yunir, E., Wafa, S., Indrasari, N. D., Iswati, E., Christabel, E. V., Widiyanti, D., Wisnu, W., Kurniawan, F., Amalina, N., Pradnjaparamita, T., et al. (2026) · Diabetology International · doi:10.1007/s13340-026-00889-3
Singh, P., Lenters‐Westra, E., Choun, K., Fasanmade, O. A., Erkoşar, B., Watson, M., Haldane, C., & Vetter, B. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-113491
“Limits of agreement (LoA) were calculated as 1.96xSD. Equivalence testing was assessed by Passing-Bablok regression, with data for each investigational device averaged across the two lots.”
Metadata
- Authors
- Hirst, J. A., McLellan, J. H., Price, C. P., English, E., Feakins, B. G., Stevens, R. J., & Farmer, A. J.
- Affiliations
- University of Oxford (GB)
- University of East Anglia (GB)
- University of Oxford, Nuffield Department of Primary Care Health Sciences, United Kingdom of Great Britain and Northern Ireland
- Corresponding author
- Hirst, Jennifer A.
- ORCID
- Venue
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Publisher
- Walter de Gruyter GmbH
- Published
- 2016-09-22
- Volume
- 55
- Issue
- 2
- Pages
- 167-180
- ISSN
- 1434-6621 (ISSN-L)
- 1437-4331
- OpenAlex
- W2522836126
- Semantic Scholar
- 8e548171bfc62f7596eb09a74b5c3e65a37fe32d
- Cited by
- 102
- References
- 68
- Citations by year
- 2026: 11 · 2025: 7 · 2024: 7 · 2023: 11 · 2022: 17 · 2021: 15 · 2020: 7 · 2019: 9 · 2018: 11 · 2017: 5 · 2016: 2
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Clinical Chemistry and Laboratory Medicine (CCLM) (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- Funders
- National Institute for Health and Care Research (DRF-2013-06-086, NF-SI-0512-10077)
- Topics
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- point-of-care testing, HbA1c, device accuracy, measurement bias, precision, diabetes management, hypoglycemia risk, HemoCue
- MeSH terms
- Glycated Hemoglobin, Humans, Practice Guidelines as Topic, Point-of-Care Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.